MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury

References

• Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239–252. doi:10.1016/S0092-8674(00)00116-1
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Takeyoshi I, Yoshinari D, et al. The role of mitogen-activated protein kinases and the participation of intestinal congestion in total hepatic ischemia-reperfusion injury. Hepatogastroenterology. 2006;53(68):243–248.
   PubMedGoogle Scholar
• Mccubrey JA, Lahair MM, Franklin RA. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal. 2006;8(9–10):1775–1789. doi:10.1089/ars.2006.8.1775
   PubMed Web of Science ®Google Scholar
• Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol. 1999;19(4):2435–2444. doi:10.1128/MCB.19.4.2435
   PubMed Web of Science ®Google Scholar
• Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2(9):717–726. doi:10.1038/nrd1177
   PubMed Web of Science ®Google Scholar
• Schnabl B, Bradham CA, Bennett BL, et al. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology. 2001;34(5):953–963. doi:10.1053/jhep.2001.28790
   PubMedGoogle Scholar
• Toledo-Pereyra LH, Toledo AH, Walsh J, et al. Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transplant. 2004;2(1):174–177.
   PubMedGoogle Scholar
• Casillas-Ramírez A, Mosbah IB, Ramalho F, et al. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 2006;79(20):1881–1894. doi:10.1016/j.lfs.2006.06.024
   PubMed Web of Science ®Google Scholar
• Saidi RF, Chang J, Brooks S, et al. Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Transplant Proc. 2007;39(10):3010–3014. doi:10.1016/j.transproceed.2007.09.044
   PubMedGoogle Scholar
• Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An Over Syn Curr Stu Transpl. 1992;53(5):957–978.
   Google Scholar
• Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125(3):917–936. doi:10.1016/S0016-5085(03)01048-5
   PubMed Web of Science ®Google Scholar
• Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147(1):153–159. doi:10.1016/j.jss.2007.06.015
   PubMed Web of Science ®Google Scholar
• Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G15–26. doi:10.1152/ajpgi.00342.2002
   PubMed Web of Science ®Google Scholar
• Gracia-Sancho J, Villarreal G, Zhang Y, et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. Transplantation. 2010;90(2):142–149. doi:10.1097/TP.0b013e3181e228db
   PubMedGoogle Scholar
• Gasbarrini A, Borle AB, Farghali H, et al. Effect of anoxia on intracellular ATP, Na+i, Ca2+i, Mg2+i, and cytotoxicity in rat hepatocytes. J Biol Chem. 1992;267(10):6654–6663. doi:10.1016/S0021-9258(19)50477-X
   PubMedGoogle Scholar
• Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol. 2000;279(1):G163–71. doi:10.1152/ajpgi.2000.279.1.G163
   PubMedGoogle Scholar
• Kalogeris T, Baines CP, Krenz M, et al. Ischemia/Reperfusion. Compr Physiol. 2016;7(1):113–170. doi:10.1002/cphy.c160006
   PubMed Web of Science ®Google Scholar
• Brown DA, Hale SL, Baines CP, et al. Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia. J Cardiovasc Pharmacol Ther. 2014;19(1):121–132. doi:10.1177/1074248413508003
   PubMed Web of Science ®Google Scholar
• Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306–321. doi:10.1038/nri.2017.11
   PubMed Web of Science ®Google Scholar
• Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440. doi:10.1002/jcp.26429
   PubMed Web of Science ®Google Scholar
• Lu TF, Yang TH, Zhong CP, et al. Dual effect of hepatic macrophages on liver ischemia and reperfusion injury during liver transplantation. Immune Netw. 2018;18(3):e24. doi:10.4110/in.2018.18.e24
   PubMed Web of Science ®Google Scholar
• Banga NR, Homer-Vanniasinkam S, Graham A, et al. Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg. 2005;92(5):528–538. doi:10.1002/bjs.5004
   PubMedGoogle Scholar
• Fan C, Zwacka RM, Engelhardt JF. Therapeutic approaches for ischemia/reperfusion injury in the liver. J Mol Med. 1999;77(8):577–592. doi:10.1007/s001099900029
   PubMedGoogle Scholar
• Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32(2):169–173. doi:10.1053/jhep.2000.9323
   PubMedGoogle Scholar
• Bradham CA, Stachlewitz RF, Gao W, et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology. 1997;25(5):1128–1135. doi:10.1002/hep.510250514
   PubMedGoogle Scholar
• Widmann C, Gibson S, Jarpe MB, et al. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev. 1999;79(1):143–180. doi:10.1152/physrev.1999.79.1.143
   PubMed Web of Science ®Google Scholar
• Han J, Lee JD, Bibbs L, et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265(5173):808–811. doi:10.1126/science.7914033
   PubMed Web of Science ®Google Scholar
• Lee JC, Laydon JT, Mcdonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372(6508):739–746. doi:10.1038/372739a0
   PubMed Web of Science ®Google Scholar
• Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, et al. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion. Hepatology. 2008;47(2):461–472. doi:10.1002/hep.21935
   PubMedGoogle Scholar
• Fernández L, Carrasco-Chaumel E, Serafín A, et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation? Am J Transplant. 2004;4(6):888–899. doi:10.1111/j.1600-6143.2004.00447.x
   PubMedGoogle Scholar
• Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, et al. Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol. 2006;168(5):1474–1485. doi:10.2353/ajpath.2006.050645
   PubMedGoogle Scholar
• Nikoletopoulou V, Markaki M, Palikaras K, et al. Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta. 2013;1833(12):3448–3459. doi:10.1016/j.bbamcr.2013.06.001
   PubMed Web of Science ®Google Scholar
• Decker RS, Wildenthal K. Lysosomal alterations in hypoxic and reoxygenated hearts. I Ultrastructural and cytochemical changes. Am J Pathol. 1980;98(2):425–444.
   PubMedGoogle Scholar
• Choi AMK, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med. 2013;368(7):651–662. doi:10.1056/NEJMra1205406
   PubMed Web of Science ®Google Scholar
• Sakoda H, Ogihara T, Anai M, et al. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am J Physiol Endocrinol Metab. 2002;282(6):E1239–44. doi:10.1152/ajpendo.00455.2001
   PubMedGoogle Scholar
• Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100(6):914–922. doi:10.1161/01.RES.0000261924.76669.36
   PubMed Web of Science ®Google Scholar
• Deng J, Feng J, Liu T, et al. Beraprost sodium preconditioning prevents inflammation, apoptosis, and autophagy during hepatic ischemia-reperfusion injury in mice via the P38 and JNK pathways. Drug Des Devel Ther. 2018;12:4067–4082.
   PubMed Web of Science ®Google Scholar
• Bejaoui M, Pantazi E, De Luca V, et al. Acetazolamide protects steatotic liver grafts against cold ischemia reperfusion injury. J Pharmacol Exp Ther. 2015;355(2):191–198. doi:10.1124/jpet.115.225177
   PubMedGoogle Scholar
• Duarte S, Shen XD, Fondevila C, et al. Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway. Am J Transplant. 2012;12(10):2689–2699. doi:10.1111/j.1600-6143.2012.04161.x
   PubMedGoogle Scholar
• Feng J, Zhang Q, Mo W, et al. Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice. Drug Des Devel Ther. 2017;11:1989–2006.
   PubMed Web of Science ®Google Scholar
• Li J, Wang F, Xia Y, et al. Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice. Mar Drugs. 2015;13(6):3368–3387. doi:10.3390/md13063368
   PubMed Web of Science ®Google Scholar
• Li S, Takahara T, Fujino M, et al. Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. PLoS One. 2017;12(11):e0187810. doi:10.1371/journal.pone.0187810
   PubMed Web of Science ®Google Scholar
• Li FF, Zhou X, Chu SF, et al. Inhibition of CKLF1 ameliorates hepatic ischemia-reperfusion injury via MAPK pathway. Cytokine. 2021;141(155429):155429. doi:10.1016/j.cyto.2021.155429
   PubMedGoogle Scholar
• Nishiyama A, Matsui M, Iwata S, et al. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem. 1999;274(31):21645–21650. doi:10.1074/jbc.274.31.21645
   PubMed Web of Science ®Google Scholar
• Szpigel A, Hainault I, Carlier A, et al. Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes. Diabetologia. 2018;61(2):399–412. doi:10.1007/s00125-017-4462-5
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Anthony TG, Wek RC. TXNIP switches tracks toward a terminal UPR. Cell Metab. 2012;16(2):135–137. doi:10.1016/j.cmet.2012.07.012
   PubMedGoogle Scholar
• Zhang Y, Miao LS, Cai YM, et al. TXNIP knockdown alleviates hepatocyte ischemia reperfusion injury through preventing p38/JNK pathway activation. Biochem Biophys Res Commun. 2018;502(3):409–414. doi:10.1016/j.bbrc.2018.05.185
   PubMedGoogle Scholar
• Schwabe RF, Brenner DA. Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G583–9. doi:10.1152/ajpgi.00422.2005
   PubMed Web of Science ®Google Scholar
• Bendinelli P, Piccoletti R, Maroni P, et al. The MAP kinase cascades are activated during post-ischemic liver reperfusion. FEBS Lett. 1996;398(2–3):193–197. doi:10.1016/S0014-5793(96)01228-8
   PubMedGoogle Scholar
• Liang R, Nickkholgh A, Hoffmann K, et al. Melatonin protects from hepatic reperfusion injury through inhibition of IKK and JNK pathways and modification of cell proliferation. J Pineal Res. 2009;46(1):8–14. doi:10.1111/j.1600-079X.2008.00596.x
   PubMed Web of Science ®Google Scholar
• Cursio R, Filippa N, Miele C, et al. Involvement of protein kinase B and mitogen-activated protein kinases in experimental normothermic liver ischaemia-reperfusion injury. Br J Surg. 2006;93(6):752–761. doi:10.1002/bjs.5329
   PubMedGoogle Scholar
• Teoh N, Dela Pena A, Farrell G. Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology. 2002;36(1):94–102. doi:10.1053/jhep.2002.33134
   PubMedGoogle Scholar
• Uehara T, Xi Peng X, Bennett B, et al. c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation. 2004;78(3):324–332. doi:10.1097/01.TP.0000128859.42696.28
   PubMedGoogle Scholar
• Uehara T, Bennett B, Sakata ST, et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol. 2005;42(6):850–859. doi:10.1016/j.jhep.2005.01.030
   PubMed Web of Science ®Google Scholar
• Lee KH, Kim SE, Lee YS. SP600125, a selective JNK inhibitor, aggravates hepatic ischemia-reperfusion injury. Exp Mol Med. 2006;38(4):408–416. doi:10.1038/emm.2006.48
   PubMedGoogle Scholar
• Huang X, Gao Y, Qin J, et al. miR-214 down-regulation promoted hypoxia/reoxygenation-induced hepatocyte apoptosis through TRAF1/ASK1/JNK pathway. Dig Dis Sci. 2019;64(5):1217–1225. doi:10.1007/s10620-018-5405-9
   PubMedGoogle Scholar
• Wang C, Chen K, Xia Y, et al. N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway. PLoS One. 2014;9(9):e108855. doi:10.1371/journal.pone.0108855
   PubMed Web of Science ®Google Scholar
• Wu H, Bai H, Duan S, et al. Downregulating serine hydroxymethyltransferase 2 deteriorates hepatic ischemia-reperfusion injury through ROS/JNK/P53 signaling in mice. Biomed Res Int. 2019;2019:2712185.
   PubMedGoogle Scholar
• Xu S, Niu P, Chen K, et al. The liver protection of propylene glycol alginate sodium sulfate preconditioning against ischemia reperfusion injury: focusing MAPK pathway activity. Sci Rep. 2017;7(1):15175. doi:10.1038/s41598-017-15521-3
   PubMedGoogle Scholar
• Rosseland CM, Wierød L, Oksvold MP, et al. Cytoplasmic retention of peroxide-activated ERK provides survival in primary cultures of rat hepatocytes. Hepatology. 2005;42(1):200–207. doi:10.1002/hep.20762
   PubMedGoogle Scholar
• Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911–1912. doi:10.1126/science.1072682
   PubMed Web of Science ®Google Scholar
• Zhai Y, Shen XD, Gao F, et al. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology. 2008;47(1):207–214. doi:10.1002/hep.21986
   PubMedGoogle Scholar
• Kang JW, Koh EJ, Lee SM. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res. 2011;50(4):403–411. doi:10.1111/j.1600-079X.2011.00858.x
   PubMed Web of Science ®Google Scholar
• Pratap A, Panakanti R, Yang N, et al. Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion. Pharm Res. 2010;27(11):2492–2504. doi:10.1007/s11095-010-0246-z
   PubMedGoogle Scholar
• Zeng S, Dun H, Ippagunta N, et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol. 2009;50(5):929–936. doi:10.1016/j.jhep.2008.11.022
   PubMedGoogle Scholar
• Pratap A, Panakanti R, Yang N, et al. Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers. Mol Pharm. 2011;8(3):958–968. doi:10.1021/mp200115v
   PubMedGoogle Scholar
• Ben Mosbah I, Alfany-Fernández I, Martel C, et al. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis. 2010;1(7):e52. doi:10.1038/cddis.2010.29
   PubMedGoogle Scholar
• Alfany-Fernandez I, Casillas-Ramirez A, Bintanel-Morcillo M, et al. Therapeutic targets in liver transplantation: angiotensin II in nonsteatotic grafts and angiotensin-(1-7) in steatotic grafts. Am J Transplant. 2009;9(3):439–451. doi:10.1111/j.1600-6143.2008.02521.x
   PubMedGoogle Scholar
• Iannelli A, De Sousa G, Zucchini N, et al. Anti-apoptotic pro-survival effect of clotrimazole in a normothermic ischemia reperfusion injury animal model. J Surg Res. 2011;171(1):101–107. doi:10.1016/j.jss.2010.03.035
   PubMedGoogle Scholar
• Park SW, Kim M, Chen SW, et al. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Invest. 2010;90(8):1209–1224. doi:10.1038/labinvest.2010.102
   PubMedGoogle Scholar
• Song J, Zhang YW, Yao AH, et al. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transpl Int. 2008;21(4):372–383. doi:10.1111/j.1432-2277.2007.00616.x
   PubMed Web of Science ®Google Scholar
• Kamo N, Shen XD, Ke B, et al. Sotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation. Am J Transplant. 2011;11(11):2499–2507. doi:10.1111/j.1600-6143.2011.03700.x
   PubMedGoogle Scholar
• EipelC C, Hübschmann U, Abshagen K, et al. Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers. J Surg Res. 2012;173(1):171–179. doi:10.1016/j.jss.2010.09.008
   PubMedGoogle Scholar
• Moore C, Shen XD, Fondevila C, et al. Fibronectin-alpha4beta1 integrin interactions modulate p42/44 MAPK phosphorylation in steatotic liver cold ischemia-reperfusion injury. Transplant Proc. 2005;37(1):432–434. doi:10.1016/j.transproceed.2004.12.206
   PubMedGoogle Scholar
• Ji J, Wu L, Feng J, et al. Cafestol preconditioning attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting ERK/PPARγ pathway. Int Immunopharmacol. 2020;84:106529.
   PubMedGoogle Scholar
• Gao Y, Zhou S, Wang F, et al. Hepatoprotective effects of limb ischemic post-conditioning in hepatic ischemic rat model and liver cancer patients via PI3K/ERK pathways. Int J Biol Sci. 2018;14(14):2037–2050. doi:10.7150/ijbs.28435
   PubMedGoogle Scholar
• Yu Q, Wu L, Liu T, et al. Protective effects of levo-tetrahydropalmatine on hepatic ischemia/reperfusion injury are mediated by inhibition of the ERK/NF-κB pathway. Int Immunopharmacol. 2019;70:435–445.
   PubMedGoogle Scholar
• Wang Y, Ni Q, Ye Q, et al. Tanshinone IIA activates autophagy to reduce liver ischemia-reperfusion injury by MEK/ERK/mTOR pathway. Pharmazie. 2018;73(7):396–401. doi:10.1691/ph.2018.7509
   PubMed Web of Science ®Google Scholar
• Kaizu T, Ikeda A, Nakao A, et al. Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G236–44. doi:10.1152/ajpgi.00144.2007
   PubMedGoogle Scholar
• Yang J, Wang Y, Sui M, et al. Tri-iodothyronine preconditioning protects against liver ischemia reperfusion injury through the regulation of autophagy by the MEK/ERK/mTORC1 axis. Biochem Biophys Res Commun. 2015;467(4):704–710. doi:10.1016/j.bbrc.2015.10.080
   PubMedGoogle Scholar
• Weijman JF, Kumar A, Jamieson SA, et al. Structural basis of autoregulatory scaffolding by apoptosis signal-regulating kinase 1. Proc Natl Acad Sci U S A. 2017;114(11):E2096–e105. doi:10.1073/pnas.1620813114
   PubMedGoogle Scholar
• Du K, Farhood A, Jaeschke H. Mitochondria-targeted antioxidant mito-tempo protects against acetaminophen hepatotoxicity. Arch Toxicol. 2017;91(2):761–773. doi:10.1007/s00204-016-1692-0
   PubMed Web of Science ®Google Scholar
• Yan ZZ, Huang YP, Wang X, et al. Integrated omics reveals tollip as an regulator and therapeutic target for hepatic ischemia-reperfusion injury in mice. Hepatology. 2019;70(5):1750–1769. doi:10.1002/hep.30705
   PubMed Web of Science ®Google Scholar
• Alchera E, Chandrashekar BR, Clemente N, et al. Ischemia/reperfusion injury of fatty liver is protected by A2AR and Exacerbated by A1R stimulation through opposite effects on ASK1 activation. Cells. 2021;10(11). doi:10.3390/cells10113171.
   PubMedGoogle Scholar
• Boldorini R, Clemente N, Alchera E, et al. DUSP12 acts as a novel endogenous protective signal against hepatic ischemia-reperfusion damage by inhibiting ASK1 pathway. Clin Sci. 2021;135(1):161–166. doi:10.1042/CS20201091
   Google Scholar
• Li TT, Luo YH, Yang H, et al. FBXW5 aggravates hepatic ischemia/reperfusion injury via promoting phosphorylation of ASK1 in a TRAF6-dependent manner. Int Immunopharmacol. 2021;99:107928.
   PubMedGoogle Scholar
• Qin JJ, Mao W, Wang X, et al. Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1. J Hepatol. 2018;69(5):1110–1122. doi:10.1016/j.jhep.2018.06.014
   PubMed Web of Science ®Google Scholar
• Zhou J, Guo L, Ma T, et al. N-acetylgalactosaminyltransferase-4 protects against hepatic ischemia/reperfusion injury by blocking apoptosis signal-regulating kinase 1 N-terminal dimerization. Hepatology. 2022;75(6):1446–1460. doi:10.1002/hep.32202
   PubMedGoogle Scholar
• Ding MJ, Fang HR, Zhang JK, et al. E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination. Hepatology. 2022;76(1):94–111. doi:10.1002/hep.32226
   PubMedGoogle Scholar
• Xia ZP, Sun L, Chen X, et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature. 2009;461(7260):114–119. doi:10.1038/nature08247
   PubMed Web of Science ®Google Scholar
• Lei CQ, Wu X, Zhong X, et al. USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB activation by deubiquitinating TAK1. J Immunol. 2019;203(1):259–268. doi:10.4049/jimmunol.1900083
   PubMedGoogle Scholar
• Zhou J, Qiu T, Wang T, et al. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling. Clin Sci. 2019;133(2):335–349. doi:10.1042/CS20180959
   Google Scholar
• Tao Q, Tianyu W, Jiangqiao Z, et al. Tripartite motif 8 deficiency relieves hepatic ischaemia/reperfusion injury via TAK1-dependent signalling pathways. Int J Biol Sci. 2019;15(8):1618–1629. doi:10.7150/ijbs.33323
   PubMed Web of Science ®Google Scholar
• Wang X, Mao W, Fang C, et al. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. J Hepatol. 2017;68(1):118–129.
   Web of Science ®Google Scholar
• Guo WZ, Fang HB, Cao SL, et al. Six-transmembrane epithelial antigen of the prostate 3 deficiency in hepatocytes protects the liver against ischemia-reperfusion injury by suppressing transforming growth factor-β-activated kinase 1. Hepatology. 2020;71(3):1037–1054. doi:10.1002/hep.30882
   PubMedGoogle Scholar
• Yang L, Wang W, Wang X, et al. Creg in hepatocytes ameliorates liver ischemia/reperfusion injury in a TAK1-dependent manner in mice. Hepatology. 2019;69(1):294–313. doi:10.1002/hep.30203
   PubMedGoogle Scholar
• Liu LM, Liang DY, Ye CG, et al. The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells. PLoS One. 2015;10(3):e0121383. doi:10.1371/journal.pone.0121383
   PubMedGoogle Scholar
• Zhang J, Wieser A, Lin H, et al. Pretreatment with zinc protects Kupffer cells following administration of microbial products. Bio Pharmaco. 2020;127:110208.
   Google Scholar
• King J, Brunel SF, Warris A. Aspergillus infections in cystic fibrosis. J Infect. 2016;72:5. doi:10.1016/j.jinf.2016.04.022
   Google Scholar
• Sengupta S, Wroblewski K, Aronsohn A, et al. Screening for zinc deficiency in patients with cirrhosis: when should we start? Dig Dis Sci. 2015;60(10):3130–3135. doi:10.1007/s10620-015-3613-0
   PubMedGoogle Scholar
• Häcker H, Redecke V, Blagoev B, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006;439(7073):204–207. doi:10.1038/nature04369
   PubMedGoogle Scholar
• Wen J, Bai H, Chen N, et al. USP25 promotes endotoxin tolerance via suppressing K48-linked ubiquitination and degradation of TRAF3 in Kupffer cells. Mol Immunol. 2019;106:53–62.
   PubMedGoogle Scholar
• Kandemir FM, Yildirim S, Kucukler S, et al. Protective effects of Morin against acrylamide-induced hepatotoxicity and nephrotoxicity: a multi-biomarker approach. Food Chem Toxicol. 2020;138:111190.
   PubMed Web of Science ®Google Scholar
• Guan MJ, Zhao N, Xie KQ, et al. Hepatoprotective effects of garlic against ethanol-induced liver injury: a mini-review. Food Chem Toxicol. 2018;111:467–473.
   PubMed Web of Science ®Google Scholar
• Nan B, Yang C, Li L, et al. Allicin alleviated acrylamide-induced NLRP3 inflammasome activation via oxidative stress and endoplasmic reticulum stress in Kupffer cells and SD rats liver. Food Chem Toxicol. 2021;148:111937.
   PubMedGoogle Scholar
• Crystal GJ, Malik G, Yoon SH, et al. Isoflurane late preconditioning against myocardial stunning is associated with enhanced antioxidant defenses. Acta Anaesthesiol Scand. 2012;56(1):39–47. doi:10.1111/j.1399-6576.2011.02583.x
   PubMedGoogle Scholar
• Hofstetter C, Boost KA, Hoegl S, et al. Norepinephrine and vasopressin counteract anti-inflammatory effects of isoflurane in endotoxemic rats. Int J Mol Med. 2007;20(4):597–604.
   PubMedGoogle Scholar
• Wang H, Wang L, Li NL, et al. Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling. Oxid Med Cell Longev. 2014;2014:851692.
   PubMed Web of Science ®Google Scholar
• Su SB, Qin SY, Xian XL, et al. Interleukin-22 regulating Kupffer cell polarization through STAT3/Erk/Akt crosstalk pathways to extenuate liver fibrosis. Life Sci. 2021;264:118677.
   PubMedGoogle Scholar
• Peng Y, Sigua CA, Murr MM. Protein kinase C-zeta mediates apoptosis of mouse Kupffer cells via ERK-1/2: a novel mechanism. Surgery. 2011;149(1):135–142. doi:10.1016/j.surg.2010.04.017
   PubMedGoogle Scholar
• Yamagoe S, Yamakawa Y, Matsuo Y, et al. Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2. Immunol Lett. 1996;52(1):9–13. doi:10.1016/0165-2478(96)02572-2
   PubMed Web of Science ®Google Scholar
• Lan F, Misu H, Chikamoto K, et al. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance. Diabetes. 2014;63(5):1649–1664. doi:10.2337/db13-0728
   PubMed Web of Science ®Google Scholar
• Chikamoto K, Misu H, Takayama H, et al. Rapid response of the steatosis-sensing hepatokine LECT2 during diet-induced weight cycling in mice. Biochem Biophys Res Commun. 2016;478(3):1310–1316. doi:10.1016/j.bbrc.2016.08.117
   PubMedGoogle Scholar
• Takata N, Ishii KA, Takayama H, et al. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH. Sci Rep. 2021;11(1):555. doi:10.1038/s41598-020-80689-0
   PubMed Web of Science ®Google Scholar
• Pu JL, Huang ZT, Luo YH, et al. Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway. Hepatobiliary Pancreat Dis Int. 2021;20(4):352–360. doi:10.1016/j.hbpd.2021.04.013
   PubMed Web of Science ®Google Scholar
• Huang Z, Mou T, Luo Y, et al. Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death Dis. 2020;11(6):455. doi:10.1038/s41419-020-2648-0
   PubMed Web of Science ®Google Scholar
• Shen A, Zheng D, Luo Y, et al. MicroRNA-24-3p alleviates hepatic ischemia and reperfusion injury in mice through the repression of STING signaling. Biochem Biophys Res Commun. 2020;522(1):47–52. doi:10.1016/j.bbrc.2019.10.182
   PubMedGoogle Scholar
• Wang X, Maretti-Mira AC, Wang L, et al. Liver-Selective MMP-9 inhibition in the rat eliminates ischemia-reperfusion injury and accelerates liver regeneration. Hepatology. 2019;69(1):314–328. doi:10.1002/hep.30169
   PubMedGoogle Scholar
• Huang Z, Zheng D, Pu J, et al. MicroRNA-125b protects liver from ischemia/reperfusion injury via inhibiting TRAF6 and NF-κB pathway. Biosci Biotechnol Biochem. 2019;83(5):829–835.
   PubMed Web of Science ®Google Scholar
• Huang Z, Pu J, Luo Y, et al. FAM49B, restrained by miR-22, relieved hepatic ischemia/reperfusion injury by inhibiting TRAF6/IKK signaling pathway in a Rac1-dependent manner. Mol Immunol. 2022;143:135–146.
   PubMedGoogle Scholar
• Li P, Zhang Z, Gong J, et al. S-Adenosylmethionine attenuates lipopolysaccharide-induced liver injury by downregulating the toll-like receptor 4 signal in Kupffer cells. Hepatol Int. 2014;8(2):275–284. doi:10.1007/s12072-014-9528-6
   PubMedGoogle Scholar